Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population-Based Cohort Study

Background Proton pump inhibitor (PPI) use has been associated with hypomagnesemia in case reports and hospital-based cohort studies. Our objective was to determine whether PPI use is associated with hypomagnesemia in the general population and whether this is also found in histamine 2 receptor anta...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of kidney diseases 2015-11, Vol.66 (5), p.775-782
Hauptverfasser:	Kieboom, Brenda C.T., MD, Kiefte–de Jong, Jessica C., RD, PhD, Eijgelsheim, Mark, MD, PhD, Franco, Oscar H., MD, PhD, Kuipers, Ernst J., MD, PhD, Hofman, Albert, MD, PhD, Zietse, Robert, MD, PhD, Stricker, Bruno H., MMed, PhD, Hoorn, Ewout J., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	acid-suppressive medication Cohort Studies Cross-Sectional Studies Diet - statistics & numerical data diuretics drug safety Epidemiology histamine 2 receptor antagonist (H2RA) Histamine H2 Antagonists - therapeutic use hypomagnesemia intestinal magnesium loss Linear Models magnesium Magnesium - blood Multivariate Analysis Nephrology population-based cohort Prospective Studies proton pump inhibitor (PPI) Proton Pump Inhibitors - therapeutic use Risk Factors Rotterdam Study Sodium Potassium Chloride Symporter Inhibitors - therapeutic use TRPM6 Water-Electrolyte Imbalance - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!